Kotak Securities’ bull-case target of 32,032 for Nifty by December 2026 is anchored in strong earnings growth, stable macro fundamentals, easing inflation, and supportive policy tailwinds.Read More
Corona Remedies’ Rs 655-crore offer-for-sale IPO saw strong demand across investor categories, with overall subscription at 144.54 times and a 28% grey market premium. Given robust institutional interest, the issue is likely to list above its Rs 1,062 price band, though final listing gains will depend on market sentiment on the listing day.Read More
Indian government bonds rallied early Thursday, mirroring a surge in U.S. Treasuries following the Federal Reserve’s 25 basis point rate cut. Despite the initial boost, traders anticipate the rally may not sustain, awaiting the Reserve Bank of India’s bond purchases for further market direction.Read More
The Indian rupee weakened today due to corporate dollar payments, overshadowing the Federal Reserve’s rate cut. Traders are watching for a potential trade deal with the U.S. and a significant Reserve Bank of India swap next week, which could influence the currency’s trajectory amidst ongoing external sector challenges.Read More
The Fed’s latest projections indicate faster growth, easing inflation and stable employment heading into 2026, offering the White House a supportive economic backdrop despite limited scope for deeper rate cuts. While tariff-driven disruptions and affordability pressures persist, policymakers project cautious stability as the election cycle approaches.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
